Nuclear‐Targeting Peptides for Cancer Therapy
ChemBioChem · 2024
DOI: 10.1002/cbic.202400596 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, 2024. Verfasst von Xuan Yi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Polymer Ecomaterials, Jilin Biomedical Polymers Engineering Laboratory, Changchun Institute of Applied Chemistry, Chinese Academy o…. Hauptthemen laut MEDLINE: Neoplasms, Cell Nucleus, Antineoplastic Agents, Peptides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 140 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jilin Provincial Science and Technology Development Program, Youth Innovation Promotion Association of CAS.
Abstract (Originalsprache)
Nucleus is the central regulator of cells that controls cell proliferation, metabolism, and cell cycle, and is considered the most important organelle in cells. The precision medicine that can achieve nuclear targeting has achieved good therapeutic effects in anti‐tumor therapy. However, the presence of biological barriers such as cell membranes and nuclear membranes in cells limit the delivery of therapeutic agents to the nucleus. Therefore, developing effective nuclear‐targeting drug delivery strategies is particularly important. Nuclear‐targeting peptides are a class of functional peptides that can penetrate cell membranes and target the nucleus. They mainly recognize and bind to the nuclear transport molecules (such as Importin‐α/β) and transport the therapeutic agents to the nucleus through nuclear pore complexes (NPC). This review summarizes the most recent developments of strategies for anti‐tumor therapy utilizing nuclear‐targeting peptides, which will ultimately contribute to the development of more effective nuclear‐targeting strategies to achieve better anti‐tumor outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Polymer Ecomaterials, Jilin Biomedical Polymers Engineering Laboratory, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P.R. China.
- Department of Chemistry and Chemical Engineering, SBA School of Science & Engineering, Lahore University of Management Sciences (LUMS). DHA, Lahore, 54792, Pakistan.
ORCID-Profile: Chunsheng Xiao
Förderung
- National Natural Science Foundation of China
- Jilin Provincial Science and Technology Development Program
- Youth Innovation Promotion Association of CAS
Zitieren
APA
Yi, X., Hussain, I., Zhang, P., & Xiao, C. (2024). Nuclear‐Targeting Peptides for Cancer Therapy. ChemBioChem. https://doi.org/10.1002/cbic.202400596
Vancouver
Yi X, Hussain I, Zhang P, Xiao C. Nuclear‐Targeting Peptides for Cancer Therapy. ChemBioChem. 2024. doi:10.1002/cbic.202400596
BibTeX
@article{Yi2024,
author = {Yi, Xuan and Hussain, Irshad and Zhang, Peng and Xiao, Chunsheng},
title = {Nuclear‐Targeting Peptides for Cancer Therapy},
journal = {ChemBioChem},
year = {2024},
doi = {10.1002/cbic.202400596}
}
EUVIMED